| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |